- Home
- LIXT vs ZCMD Comparison
LIXT vs ZCMD Comparison
Compare LIXT & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- ZCMD
- Stock Information
- Founded
- LIXT 2005
- ZCMD 2012
- Country
- LIXT United States
- ZCMD China
- Employees
- LIXT N/A
- ZCMD N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- LIXT Health Care
- ZCMD Real Estate
- Exchange
- LIXT Nasdaq
- ZCMD Nasdaq
- Market Cap
- LIXT 20.5M
- ZCMD 16.8M
- IPO Year
- LIXT N/A
- ZCMD 2020
- Fundamental
- Price
- LIXT $4.00
- ZCMD $0.60
- Analyst Decision
- LIXT
- ZCMD
- Analyst Count
- LIXT 0
- ZCMD 0
- Target Price
- LIXT N/A
- ZCMD N/A
- AVG Volume (30 Days)
- LIXT 86.0K
- ZCMD 28.5K
- Earning Date
- LIXT 11-12-2025
- ZCMD 01-01-0001
- Dividend Yield
- LIXT N/A
- ZCMD N/A
- EPS Growth
- LIXT N/A
- ZCMD N/A
- EPS
- LIXT N/A
- ZCMD N/A
- Revenue
- LIXT N/A
- ZCMD $13,117,523.00
- Revenue This Year
- LIXT N/A
- ZCMD N/A
- Revenue Next Year
- LIXT N/A
- ZCMD N/A
- P/E Ratio
- LIXT N/A
- ZCMD N/A
- Revenue Growth
- LIXT N/A
- ZCMD N/A
- 52 Week Low
- LIXT $0.64
- ZCMD $0.54
- 52 Week High
- LIXT $6.26
- ZCMD $2.50
- Technical
- Relative Strength Index (RSI)
- LIXT 41.53
- ZCMD 34.28
- Support Level
- LIXT $4.14
- ZCMD $0.54
- Resistance Level
- LIXT $4.49
- ZCMD $0.69
- Average True Range (ATR)
- LIXT 0.42
- ZCMD 0.06
- MACD
- LIXT 0.00
- ZCMD 0.00
- Stochastic Oscillator
- LIXT 34.03
- ZCMD 22.67
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.